FertiloSure Combo
The FertiloSure Combo Test offers a comprehensive assessment of female fertility by evaluating two critical hormones:
AMH (Anti-Müllerian Hormone) and FSH (Follicle-Stimulating Hormone). This test measures AMH to determine ovarian reserve and FSH to assess the ovaries’ ability to support egg maturation and ovulation. Together, these insights provide dual validation, enabling accurate detection of fertility issues such as diminished ovarian reserve or early menopause risk. Designed for use in clinics or labs, the FertiloSure Combo Test is particularly valuable for women planning pregnancy, undergoing fertility treatments like IVF, or monitoring reproductive health across life stages.
FertiloSure Combo
A Comprehensive Home Fertility Test
The FertiloSure Combo Test offers a comprehensive assessment of female fertility by evaluating two critical hormones:
1. Anti-Müllerian Hormone (AMH):
- AMH levels reflect the ovarian reserve, providing insights into the quantity of eggs remaining in the ovaries.
- It is a reliable marker for assessing fertility potential and predicting ovarian response for treatments like IVF.
2. Follicle-Stimulating Hormone (FSH):
- FSH regulates the menstrual cycle and stimulates the growth of ovarian follicles.
- Elevated FSH levels may indicate diminished ovarian reserve or reduced fertility potential.
Why is Combo Test needed?
- Comprehensive Fertility Assessment: The combined measurement of AMH and FSH offers a holistic view of ovarian health, enabling early detection of potential fertility issues.
- Personalized Insights: Provides actionable data to guide fertility planning and treatment decisions.
- Convenience: The test is designed for quick and easy processing, making it accessible for use in clinics, labs, and potentially home-based settings.
This combo test is an invaluable test for women planning pregnancy, undergoing fertility treatments, or monitoring reproductive health over time.